107 related articles for article (PubMed ID: 7783317)
1. [Postantibiotic effects (PAE's) of macrolide antibiotics evaluated using Bioscreen C method].
Okubo T; Suzuki T; Fujita K; Iyobe S; Inoue M
Jpn J Antibiot; 1995 Apr; 48(4):548-52. PubMed ID: 7783317
[TBL] [Abstract][Full Text] [Related]
2. Effects of macrolides on ultrastructure of Staphylococcus aureus during postantibiotic phase.
Watanabe T; Kanno M; Tejima E; Orikasa Y
Drugs Exp Clin Res; 1992; 18(3):81-8. PubMed ID: 1425207
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
[TBL] [Abstract][Full Text] [Related]
4. Implication of cohesive binding of a macrolide antibiotic, rokitamycin, to ribosomes from Staphylococcus aureus.
Endou K; Matsuoka M; Taniguchi H; Nakajima Y
J Antibiot (Tokyo); 1993 Mar; 46(3):478-85. PubMed ID: 8478265
[TBL] [Abstract][Full Text] [Related]
5. [Bacteriological, pharmacokinetic and clinical studies on a rokitamycin dry syrup in the pediatric field].
Toyonaga Y; Sugita M; Joh K; Takahashi T; Watanabe Y; Hori M
Jpn J Antibiot; 1988 Jun; 41(6):720-38. PubMed ID: 3265445
[TBL] [Abstract][Full Text] [Related]
6. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Nishiyama T; Yamashita F
Jpn J Antibiot; 1988 Oct; 41(10):1503-16. PubMed ID: 3204657
[TBL] [Abstract][Full Text] [Related]
7. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts.
Maizumi N; Tamura Y; Kanai H; Tsutsui T
J Periodontal Res; 2002 Aug; 37(4):250-4. PubMed ID: 12200967
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of YM133, a new semisynthesized macrolide.
Terasawa T; Watanabe M; Okubo T; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jul; 35(7):1370-5. PubMed ID: 1929295
[TBL] [Abstract][Full Text] [Related]
9. Novel method for assessing postantibiotic effect by using the Coulter counter.
Li RC; Lee SW; Lam JS
Antimicrob Agents Chemother; 1996 Jul; 40(7):1751-3. PubMed ID: 8807079
[TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
Okubo T; Iyobe S; Fujiki Y; Sagai H
Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
[TBL] [Abstract][Full Text] [Related]
11. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci.
Varotto F; Garlaschi ML; Garlaschi MC; Falchi M; Scaglione F; Cattaneo G; De Luca M; Fraschini F
J Chemother; 1990 Dec; 2(6):355-61. PubMed ID: 2093106
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Chida T; Nakaya R
Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
[TBL] [Abstract][Full Text] [Related]
13. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.
Hanberger H; Nilsson LE; Maller R; Isaksson B
Antimicrob Agents Chemother; 1991 Sep; 35(9):1710-6. PubMed ID: 1659305
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of rokitamycin against problem gram-positive cocci.
Hamilton-Miller JM; Maple PA
J Chemother; 1992 Feb; 4(1):6-8. PubMed ID: 1403073
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial activity of rokitamycin against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Dec; 45(12):1609-21. PubMed ID: 1289579
[TBL] [Abstract][Full Text] [Related]
17. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K
Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis and intracellular killing of rokitamycin-exposed staphylococci by human polymorphonuclear leukocytes.
Braga PC; Sala MT; Mancini L; Da Sasso M
Chemotherapy; 1998; 44(1):42-9. PubMed ID: 9444408
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antibacterial activities of clarithromycin.
Ono T; Numata K; Nagate T; Mitsuhashi S; Inoue M
Chemotherapy; 1996; 42(3):159-69. PubMed ID: 8983882
[TBL] [Abstract][Full Text] [Related]
20. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
Braga PC; Culici M; Dal Sasso M
Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
